Latest Update: Impact of current COVID-19 situation has been considered in this report while making the analysis.
Global Axial Spondyloarthritis Treatment Market by Type (Medical Treatement, Physiotherapy Treatement), By Application (Hospital, Rehabilitation Center, Other) and Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030-report

Global Axial Spondyloarthritis Treatment Market by Type (Medical Treatement, Physiotherapy Treatement), By Application (Hospital, Rehabilitation Center, Other) and Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030

Report ID: 312300 4200 Medical Care 377 190 Pages 4.5 (34)
                                          

Market Overview:


The global axial spondyloarthritis treatment market is expected to grow at a CAGR of 5.5% from 2018 to 2030. The growth in the market can be attributed to factors such as the increasing prevalence of axial spondyloarthritis, rising awareness about available treatments, and technological advancements in the field of medical treatment for axial spondyloarthritis. The global axial spondyloarthritis treatment market is segmented on the basis of type, application, and region. On the basis of type, the market is segmented into medical treatment and physiotherapy treatment. Medical treatments are further sub-segmented into drugs and surgery. Physiotherapy treatments are further sub-segmented into exercises and traction therapy. On the basis of application, the market is segmented into hospitals, rehabilitation centers, and other applications such as clinics or individual homes settings etcetera). Geographically,the global Axial Spondyalartitis Treatment Marketis dividedinto five regions: North America (U S A Canada), Latin America (Brazil Mexico Argentina), Europe (Germany France Italy Spain United Kingdom), Asia Pacific(Japan China India South Korea Australia New Zealand)and Middle East Africa(GCC Countries Turkey Iran Israel South Africa).


Global Axial Spondyloarthritis Treatment Industry Outlook


Product Definition:


Axial spondyloarthritis is a type of arthritis that affects the spine. It is marked by inflammation and pain in the joints between the vertebrae, as well as stiffness and reduced range of motion. Treatment for axial spondyloarthritis may include medications to reduce inflammation, such as NSAIDs or corticosteroids, and injections of numbing agents or steroids into affected joints. Physical therapy may also be recommended to help improve mobility and strength.


Medical Treatement:


Medical treatment or therapy is the use of medications, therapies and other medical devices by doctors to diagnose and treat diseases. Medical treatments can be categorized into two types: curative care which aims at curing the disease completely and preventive care which aims at preventing disease occurrence.


Physiotherapy Treatement:


Physiotherapy is a treatment plan that helps patients achieve their maximum potential through the use of physical agents. The most common physiotherapy techniques include exercise, occupational therapy, and relaxation therapies. Axial spondyloarthritis (ASA) is a degenerative disorder of the spine and neck caused by wear debris in the joints which leads to inflammation & cartilage damage.


Application Insights:


The hospital application segment dominated the market for global axial spondyloarthritis treatment, accounting for a share of 60.1% in 2017. The dominance is attributed to factors such as availability of advanced healthcare facilities and highly skilled medical staff in hospitals across the globe. In addition, an increase in prevalence rates increases the number of patients visiting hospitals with related symptoms, thereby increasing demand for axial spondyloarthritis treatment at these centers over the forecast period.


Rehabilitation centers are anticipated to witness lucrative growth over the forecast period due to factors such as favorable government initiatives and increased spending on health care services by companies operating within this sector globally.


Regional Analysis:


North America dominated the global market in 2017. The presence of key players, favorable reimbursement policies, and increasing geriatric population are some of the factors responsible for its growth. According to a study published in Arthritis Care & Research, axial spondyloarthritis is more common among individuals aged 65 years and older.


Asia Pacific region is anticipated to grow at a lucrative rate during the forecast period owing to rising disposable income leading towards increased healthcare expenditure by governments as well as private sectors coupled with growing awareness about early diagnosis and effective treatment methods for AXSAA disorders.


Growth Factors:


  • Increasing incidence of axial spondyloarthritis
  • Growing awareness about the disease and its treatment options
  • Rising demand for novel and effective therapies for axial spondyloarthritis
  • Availability of government funding for research on axial spondyloarthritis treatments
  • Technological advancements in the field of axial spondyloarthritis treatment

Scope Of The Report

Report Attributes

Report Details

Report Title

Axial Spondyloarthritis Treatment Market Research Report

By Type

Medical Treatement, Physiotherapy Treatement

By Application

Hospital, Rehabilitation Center, Other

By Companies

UCB Biosciences, Pfizer, Abbott Pharmaceuticals, Merck Sharp & Dohme, GlaxoSmithKline

Regions Covered

North America, Europe, APAC, Latin America, MEA

Base Year

2021

Historical Year

2019 to 2020 (Data from 2010 can be provided as per availability)

Forecast Year

2030

Number of Pages

190

Number of Tables & Figures

133

Customization Available

Yes, the report can be customized as per your need.


Global Axial Spondyloarthritis Treatment Market Report Segments:

The global Axial Spondyloarthritis Treatment market is segmented on the basis of:

Types

Medical Treatement, Physiotherapy Treatement

The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.

Applications

Hospital, Rehabilitation Center, Other

The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.

Some of the companies that are profiled in this report are:

  1. UCB Biosciences
  2. Pfizer
  3. Abbott Pharmaceuticals
  4. Merck Sharp & Dohme
  5. GlaxoSmithKline

Global Axial Spondyloarthritis Treatment Market Overview


Highlights of The Axial Spondyloarthritis Treatment Market Report:

  1. The market structure and projections for the coming years.
  2. Drivers, restraints, opportunities, and current trends of market.
  3. Historical data and forecast.
  4. Estimations for the forecast period 2030.
  5. Developments and trends in the market.
  6. By Type:

    1. Medical Treatement
    2. Physiotherapy Treatement
  1. By Application:

    1. Hospital
    2. Rehabilitation Center
    3. Other
  1. Market scenario by region, sub-region, and country.
  2. Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
  3. Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
  4. Government Policies, Macro & Micro economic factors are also included in the report.

We have studied the Axial Spondyloarthritis Treatment Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.

Regional Analysis

  • North America
  • Europe
  • Asia Pacific
  • Middle East & Africa
  • Latin America

Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.

The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.

How you may use our products:

  • Correctly Positioning New Products
  • Market Entry Strategies
  • Business Expansion Strategies
  • Consumer Insights
  • Understanding Competition Scenario
  • Product & Brand Management
  • Channel & Customer Management
  • Identifying Appropriate Advertising Appeals

Global Axial Spondyloarthritis Treatment Market Statistics

8 Reasons to Buy This Report

  1. Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
  2. Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
  3. Implemented Robust Methodology to Prepare the Report
  4. Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
  5. Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
  6. Provides Information About the Top-winning Strategies Implemented by Industry Players.
  7. In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
  8. Customization of the Report Available

Frequently Asked Questions?


Axial spondyloarthritis is a type of arthritis that affects the spine. Treatment typically includes medications, physical therapy, and surgery.

Some of the key players operating in the axial spondyloarthritis treatment market are UCB Biosciences, Pfizer, Abbott Pharmaceuticals, Merck Sharp & Dohme, GlaxoSmithKline.

The axial spondyloarthritis treatment market is expected to grow at a compound annual growth rate of 5.5%.

                                            
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Axial Spondyloarthritis Treatment Market Overview    4.1 Introduction       4.1.1 Market Taxonomy       4.1.2 Market Definition       4.1.3 Macro-Economic Factors Impacting the Market Growth    4.2 Axial Spondyloarthritis Treatment Market Dynamics       4.2.1 Market Drivers       4.2.2 Market Restraints       4.2.3 Market Opportunity    4.3 Axial Spondyloarthritis Treatment Market - Supply Chain Analysis       4.3.1 List of Key Suppliers       4.3.2 List of Key Distributors       4.3.3 List of Key Consumers    4.4 Key Forces Shaping the Axial Spondyloarthritis Treatment Market       4.4.1 Bargaining Power of Suppliers       4.4.2 Bargaining Power of Buyers       4.4.3 Threat of Substitution       4.4.4 Threat of New Entrants       4.4.5 Competitive Rivalry    4.5 Global Axial Spondyloarthritis Treatment Market Size & Forecast, 2020-2028       4.5.1 Axial Spondyloarthritis Treatment Market Size and Y-o-Y Growth       4.5.2 Axial Spondyloarthritis Treatment Market Absolute $ Opportunity

Chapter 5 Global  Market Analysis and Forecast by Type
   5.1 Introduction
      5.1.1 Key Market Trends & Growth Opportunities by Type
      5.1.2 Basis Point Share (BPS) Analysis by Type
      5.1.3 Absolute $ Opportunity Assessment by Type
   5.2  Market Size Forecast by Type
      5.2.1 Medical Treatement
      5.2.2 Physiotherapy Treatement
   5.3 Market Attractiveness Analysis by Type

Chapter 6 Global  Market Analysis and Forecast by Applications
   6.1 Introduction
      6.1.1 Key Market Trends & Growth Opportunities by Applications
      6.1.2 Basis Point Share (BPS) Analysis by Applications
      6.1.3 Absolute $ Opportunity Assessment by Applications
   6.2  Market Size Forecast by Applications
      6.2.1 Hospital
      6.2.2 Rehabilitation Center
      6.2.3 Other
   6.3 Market Attractiveness Analysis by Applications

Chapter 7 Global Axial Spondyloarthritis Treatment Market Analysis and Forecast by Region
   7.1 Introduction
      7.1.1 Key Market Trends & Growth Opportunities by Region
      7.1.2 Basis Point Share (BPS) Analysis by Region
      7.1.3 Absolute $ Opportunity Assessment by Region
   7.2 Axial Spondyloarthritis Treatment Market Size Forecast by Region
      7.2.1 North America
      7.2.2 Europe
      7.2.3 Asia Pacific
      7.2.4 Latin America
      7.2.5 Middle East & Africa (MEA)
   7.3 Market Attractiveness Analysis by Region

Chapter 8 Coronavirus Disease (COVID-19) Impact 
   8.1 Introduction 
   8.2 Current & Future Impact Analysis 
   8.3 Economic Impact Analysis 
   8.4 Government Policies 
   8.5 Investment Scenario

Chapter 9 North America  Analysis and Forecast
   9.1 Introduction
   9.2 North America  Market Size Forecast by Country
      9.2.1 U.S.
      9.2.2 Canada
   9.3 Basis Point Share (BPS) Analysis by Country
   9.4 Absolute $ Opportunity Assessment by Country
   9.5 Market Attractiveness Analysis by Country
   9.6 North America  Market Size Forecast by Type
      9.6.1 Medical Treatement
      9.6.2 Physiotherapy Treatement
   9.7 Basis Point Share (BPS) Analysis by Type 
   9.8 Absolute $ Opportunity Assessment by Type 
   9.9 Market Attractiveness Analysis by Type
   9.10 North America  Market Size Forecast by Applications
      9.10.1 Hospital
      9.10.2 Rehabilitation Center
      9.10.3 Other
   9.11 Basis Point Share (BPS) Analysis by Applications 
   9.12 Absolute $ Opportunity Assessment by Applications 
   9.13 Market Attractiveness Analysis by Applications

Chapter 10 Europe  Analysis and Forecast
   10.1 Introduction
   10.2 Europe  Market Size Forecast by Country
      10.2.1 Germany
      10.2.2 France
      10.2.3 Italy
      10.2.4 U.K.
      10.2.5 Spain
      10.2.6 Russia
      10.2.7 Rest of Europe
   10.3 Basis Point Share (BPS) Analysis by Country
   10.4 Absolute $ Opportunity Assessment by Country
   10.5 Market Attractiveness Analysis by Country
   10.6 Europe  Market Size Forecast by Type
      10.6.1 Medical Treatement
      10.6.2 Physiotherapy Treatement
   10.7 Basis Point Share (BPS) Analysis by Type 
   10.8 Absolute $ Opportunity Assessment by Type 
   10.9 Market Attractiveness Analysis by Type
   10.10 Europe  Market Size Forecast by Applications
      10.10.1 Hospital
      10.10.2 Rehabilitation Center
      10.10.3 Other
   10.11 Basis Point Share (BPS) Analysis by Applications 
   10.12 Absolute $ Opportunity Assessment by Applications 
   10.13 Market Attractiveness Analysis by Applications

Chapter 11 Asia Pacific  Analysis and Forecast
   11.1 Introduction
   11.2 Asia Pacific  Market Size Forecast by Country
      11.2.1 China
      11.2.2 Japan
      11.2.3 South Korea
      11.2.4 India
      11.2.5 Australia
      11.2.6 South East Asia (SEA)
      11.2.7 Rest of Asia Pacific (APAC)
   11.3 Basis Point Share (BPS) Analysis by Country
   11.4 Absolute $ Opportunity Assessment by Country
   11.5 Market Attractiveness Analysis by Country
   11.6 Asia Pacific  Market Size Forecast by Type
      11.6.1 Medical Treatement
      11.6.2 Physiotherapy Treatement
   11.7 Basis Point Share (BPS) Analysis by Type 
   11.8 Absolute $ Opportunity Assessment by Type 
   11.9 Market Attractiveness Analysis by Type
   11.10 Asia Pacific  Market Size Forecast by Applications
      11.10.1 Hospital
      11.10.2 Rehabilitation Center
      11.10.3 Other
   11.11 Basis Point Share (BPS) Analysis by Applications 
   11.12 Absolute $ Opportunity Assessment by Applications 
   11.13 Market Attractiveness Analysis by Applications

Chapter 12 Latin America  Analysis and Forecast
   12.1 Introduction
   12.2 Latin America  Market Size Forecast by Country
      12.2.1 Brazil
      12.2.2 Mexico
      12.2.3 Rest of Latin America (LATAM)
   12.3 Basis Point Share (BPS) Analysis by Country
   12.4 Absolute $ Opportunity Assessment by Country
   12.5 Market Attractiveness Analysis by Country
   12.6 Latin America  Market Size Forecast by Type
      12.6.1 Medical Treatement
      12.6.2 Physiotherapy Treatement
   12.7 Basis Point Share (BPS) Analysis by Type 
   12.8 Absolute $ Opportunity Assessment by Type 
   12.9 Market Attractiveness Analysis by Type
   12.10 Latin America  Market Size Forecast by Applications
      12.10.1 Hospital
      12.10.2 Rehabilitation Center
      12.10.3 Other
   12.11 Basis Point Share (BPS) Analysis by Applications 
   12.12 Absolute $ Opportunity Assessment by Applications 
   12.13 Market Attractiveness Analysis by Applications

Chapter 13 Middle East & Africa (MEA)  Analysis and Forecast
   13.1 Introduction
   13.2 Middle East & Africa (MEA)  Market Size Forecast by Country
      13.2.1 Saudi Arabia
      13.2.2 South Africa
      13.2.3 UAE
      13.2.4 Rest of Middle East & Africa (MEA)
   13.3 Basis Point Share (BPS) Analysis by Country
   13.4 Absolute $ Opportunity Assessment by Country
   13.5 Market Attractiveness Analysis by Country
   13.6 Middle East & Africa (MEA)  Market Size Forecast by Type
      13.6.1 Medical Treatement
      13.6.2 Physiotherapy Treatement
   13.7 Basis Point Share (BPS) Analysis by Type 
   13.8 Absolute $ Opportunity Assessment by Type 
   13.9 Market Attractiveness Analysis by Type
   13.10 Middle East & Africa (MEA)  Market Size Forecast by Applications
      13.10.1 Hospital
      13.10.2 Rehabilitation Center
      13.10.3 Other
   13.11 Basis Point Share (BPS) Analysis by Applications 
   13.12 Absolute $ Opportunity Assessment by Applications 
   13.13 Market Attractiveness Analysis by Applications

Chapter 14 Competition Landscape 
   14.1 Axial Spondyloarthritis Treatment Market: Competitive Dashboard
   14.2 Global Axial Spondyloarthritis Treatment Market: Market Share Analysis, 2019
   14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy) 
      14.3.1 UCB Biosciences
      14.3.2 Pfizer
      14.3.3 Abbott Pharmaceuticals
      14.3.4 Merck Sharp & Dohme
      14.3.5 GlaxoSmithKline

Our Trusted Clients

Contact Us